Form 15-12G - Securities registration termination [Section 12(g)]
October 16 2023 - 4:15PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION
UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934.
Commission
File Number: 001-41116
BioPlus
Acquisition Corp.
(Exact
name of registrant as specified in its charter)
260
Madison Avenue
Suite
800
New
York, New York 10026
(212)
287-4092
(Address,
including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Units,
each consisting of one Class A Ordinary Share and one-half of one Redeemable Warrant
Class
A Ordinary Shares, par value $0.0001 per share
Warrants,
each exercisable for one Class A Ordinary Share for $11.50 per share
(Title
of each class of securities covered by this Form)
None
(Titles
of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please
place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) |
☒ |
|
Rule 12g-4(a)(2) |
☐ |
|
Rule 12h-3(b)(1)(i) |
☒ |
|
Rule 12h-3(b)(1)(ii) |
☐ |
|
Rule 15d-6 |
☐ |
|
Rule 15-22(b) |
☐ |
|
Approximate
number of holders of record as of the certification or notice date: 1
Pursuant
to the requirements of the Securities Exchange Act of 1934, BioPlus Acquisition Corp. has caused this certification/notice to be signed
on its behalf by the undersigned duly authorized person.
Dated:
October 16, 2023
|
BIOPLUS
ACQUISITION CORP. |
|
|
|
By: |
/s/
Ross Haghighat |
|
Name: |
Ross
Haghighat |
|
Title: |
Chief
Executive Officer and
Chief Financial Officer |
BioPlus Acquisition (NASDAQ:BIOSU)
Historical Stock Chart
From Oct 2024 to Nov 2024
BioPlus Acquisition (NASDAQ:BIOSU)
Historical Stock Chart
From Nov 2023 to Nov 2024